The following is a summary of “Biological characterization and clinical significance of cuproptosis-related genes in lung ...

引言如何在早期阶段精准诊断并评估癌症患者的预后风险，一直是一项具有重大挑战的课题。循环肿瘤DNA (circulating tumor DNA, ctDNA) ...

Ultrasensitive ctDNA detection with NeXT Personal shows 81% sensitivity in early-stage lung adenocarcinoma, improving ...

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...

A California man tragically succumbed to lung cancer transmitted from a deceased organ donor in a rare medical case. This ...

In a study involving 171 subjects with early-stage non-small cell lung cancer (NSCLC) from the TRACERx cohort, NeXT Personal ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumour DNA can predict lung cancer outcome in a Cancer Research UK-funded study.

Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Charles Swanton and his colleagues at London’s Francis Crick Institute and University ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA can predict lung cancer outcome in a Cancer Research UK-funded study.

Personalis (PSNL) published new results from their TRACERx lung cancer study in Nature Medicine. In this study, co-authors Black and Bartha et ...